Company
United StatesPublic company, NASDAQ: BCDABioCardia, Inc. (NASDAQ: BCDA), Sunnyvale, CA – FDA Inspections
Inspection records and compliance data for BioCardia, Inc. in Sunnyvale, California. 4 FDA inspections on record, last inspected April 10, 2023. Publicly traded as NASDAQ: BCDA.
Company Profile
This profile covers BioCardia, Inc. based in Sunnyvale, California, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 0
- NAI
- 4
- Form 483s
- 0
- Warning letters
- 0
First inspected June 15, 2010. Last inspected April 10, 2023.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 10, 2023 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1202556 |
| March 4, 2016 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 971056 |
| February 14, 2013 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 818869 |
| June 15, 2010 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 664347 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
BioCardia, Inc.
Stock ticker
BCDA
Exchange
NASDAQ
Share price
$0.89
Market cap
$13.4M
Price as of
November 6, 2026
FEI Number
3003610571
Address
320 Soquel Way, Sunnyvale, California 94085, United States
Country
United States
ID: 1b8abb9f-0a58-4283-b9a5-edb548ad2fb7